| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |